Condition
Circulating Tumor DNA Methylation clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Circulating Tumor DNA Methylation clinical trials that are recruiting, in China. By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Using ctDNA methylation to guide chemotherapy for high-risk colorectal cancer
This study is testing whether using a blood test to check for cancer DNA can help doctors choose the best chemotherapy for patients with high-risk colorectal cancer after surgery to improve their chances of recovery.
-
Monitoring tumor DNA methylation after surgery for colorectal cancer
This study is testing if checking for tumor DNA in the blood after surgery can help doctors better monitor recovery and spot any signs of colorectal cancer coming back in patients who are at high risk.
Related topics
Quick answers
How many Circulating Tumor DNA Methylation clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.